Edition:
India

Five Prime Therapeutics Announces Third Quarter 2018 Financial Results


Wednesday, 7 Nov 2018 

Nov 6 (Reuters) - Five Prime Therapeutics Inc ::FIVE PRIME THERAPEUTICS ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $1.37.Q3 EARNINGS PER SHARE VIEW $-1.15 -- THOMSON REUTERS I/B/E/S.COLLABORATION AND LICENSE REVENUE FOR Q3 OF 2018 DECREASED BY $2.5 MILLION, OR 30%, TO $5.8 MILLION FROM $8.3 MILLION FOR Q3 OF 2017.FIVE PRIME EXPECTS FULL-YEAR 2018 NET CASH USED IN OPERATING ACTIVITIES TO BE LESS THAN $135 MILLION.NOW ESTIMATES ENDING 2018 WITH APPROXIMATELY $265 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES. 

Company Quote

3.54
0.22 +6.63%
2:29am IST